Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New training aims to improve End-of-Life care for african americans

NCT ID NCT05908487

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study trains palliative care doctors and nurses to better understand and respect the cultural values of older African American patients. The goal is to improve communication and reduce the impact of racism in end-of-life care. Researchers will test if the training helps patients and families feel more connected to their clinicians.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Aim 1.1 Person with serious Illness: * Self-identified as African American (i.e., born, raised, and lived primarily in the US) * Non-Hispanic or Latino * Age ≥60 years * English-speaking * Has been diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro-degenerative disease, renal disease, stroke, sepsis, hepatic disease) * Callahan Six-Item Screener score ≥4 * Able to complete baseline surveys. Bereaved family member: * Self-identified as African American (i.e., born, raised, and lived primarily in the US) * Non-Hispanic or Latino * Age ≥60 years * English-speaking * Loved one dies in the last 12 months and was diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro- degenerative disease, renal disease, stroke, sepsis, hepatic disease) * Callahan Six-Item Screener score ≥4 * Able to complete baseline surveys. Exclusion Criteria Person with serious illness: -Cannot be receiving hospice care Bereaved Family Member: -Cannot be a paid "sitter" Inclusion Criteria: Aim 1.2 Bereaved Family member: * Self-identified as African American (i.e., born, raised, and lived primarily in the US) * Non-Hispanic or Latino * Age ≥60 years * English-speaking * Loved one dies in the last 12 months and was diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro- degenerative disease, renal disease, stroke, sepsis, hepatic disease) * Callahan Six-Item Screener score ≥4 * Able to complete baseline surveys Pastors: * Self-identifying as African American * White, Non-Hispanic or Latino * Sged ≥18 years old. Inclusion Criteria: Aim 3 Clinician eligibility: * Practice at a University of Alabama at Birmingham (UAB) or Montefiore/Einstein site that provides care to patients eligible for outcomes surveys * At least 3 months of clinical practice at the study site prior to the intervention training to measure pre-intervention patient surveys Exclusion criteria: -Lack of at least 3 months of clinical practice at the study site prior to the intervention training. Patient eligibility: * Self-identified as African American (i.e., born, raised, and lived primarily in the US) * Non-Hispanic or Latino, 3. age ≥60 years * English-speaking * Has been diagnosed with a condition that fits into one of 3 illness paradigms including cancer, cardiac disease, pulmonary disease, neuro-degenerative disease, renal disease, stroke, sepsis, hepatic disease) * Callahan Six-Item Screener score ≥4 * Able to complete baseline surveys. Exclusion criteria include: -Currently receiving hospice care. Family member eligibility: * Age ≥ 18 years * English-speaking * Community-dwelling * Unpaid care provider of a person with a serious illness. Exclusion criteria: 1. Cannot be a paid "sitter".

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Care eliciting behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior CGF1 Systemic Racism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Albert Einstein/Montefiore

    RECRUITING

    The Bronx, New York, 10461, United States

  • UAB

    RECRUITING

    Birmingham, Alabama, 35233, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.